XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 3,000 $ 82,928,000 $ (67,741,000) $ 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Common Stock issued to directors 38,000 38,000
Common Stock issued to directors (in Shares) 12,323      
Stock-Based Compensation 24,000 24,000
Net Loss (706,000) (706,000)
Balance at Mar. 31, 2024 $ 3,000 82,990,000 (68,447,000) 14,546,000
Balance (in Shares) at Mar. 31, 2024 3,315,368      
Balance at Dec. 31, 2023 $ 3,000 82,928,000 (67,741,000) 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Common Stock issued to directors       116,000
Stock-Based Compensation       186,000
Net Loss       (812,000)
Balance at Sep. 30, 2024 $ 3,000 83,230,000 (68,553,000) 14,680,000
Balance (in Shares) at Sep. 30, 2024 3,350,791      
Balance at Dec. 31, 2023 $ 3,000 82,928,000 (67,741,000) 15,190,000
Balance (in Shares) at Dec. 31, 2023 3,303,045      
Balance at Dec. 31, 2024 $ 3,000 84,052,000 (69,107,000) 14,948,000
Balance (in Shares) at Dec. 31, 2024 3,474,970      
Balance at Mar. 31, 2024 $ 3,000 82,990,000 (68,447,000) 14,546,000
Balance (in Shares) at Mar. 31, 2024 3,315,368      
Common Stock issued to directors 38,000 38,000
Common Stock issued to directors (in Shares) 7,942      
Stock-Based Compensation 12,000 12,000
Exercise of Stock Options
Exercise of Stock Options (in Shares) 1,475      
Net Loss 298,000 298,000
Balance at Jun. 30, 2024 $ 3,000 83,040,000 (68,149,000) 14,894,000
Balance (in Shares) at Jun. 30, 2024 3,324,785      
Common Stock issued to directors 40,000 40,000
Common Stock issued to directors (in Shares) 12,252      
Stock-Based Compensation 150,000 150,000
Exercise of Stock Options
Exercise of Stock Options (in Shares) 13,754      
Net Loss (404,000) (404,000)
Balance at Sep. 30, 2024 $ 3,000 83,230,000 (68,553,000) 14,680,000
Balance (in Shares) at Sep. 30, 2024 3,350,791      
Balance at Dec. 31, 2024 $ 3,000 84,052,000 (69,107,000) 14,948,000
Balance (in Shares) at Dec. 31, 2024 3,474,970      
Common Stock issued to directors 39,000 39,000
Common Stock issued to directors (in Shares) 9,185      
Stock-Based Compensation 435,000 435,000
Common Stock issued for cash $ 1,000 854,000 855,000
Common Stock issued for cash (in Shares) 209,940      
Net Loss (988,000) (988,000)
Balance at Mar. 31, 2025 $ 4,000 85,380,000 (70,095,000) 15,289,000
Balance (in Shares) at Mar. 31, 2025 3,694,095      
Balance at Dec. 31, 2024 $ 3,000 84,052,000 (69,107,000) 14,948,000
Balance (in Shares) at Dec. 31, 2024 3,474,970      
Common Stock issued to directors       92,000
Stock-Based Compensation       744,000
Net Loss       (1,454,000)
Balance at Sep. 30, 2025 $ 5,000 89,399,000 (70,561,000) 18,843,000
Balance (in Shares) at Sep. 30, 2025 4,771,954      
Balance at Mar. 31, 2025 $ 4,000 85,380,000 (70,095,000) 15,289,000
Balance (in Shares) at Mar. 31, 2025 3,694,095      
Common Stock issued to directors 39,000 39,000
Common Stock issued to directors (in Shares) 12,950      
Stock-Based Compensation 157,000 157,000
Common Stock issued for cash 330,000 330,000
Common Stock issued for cash (in Shares) 97,866      
Common Stock issued upon settlement of restricted stock units, net (127,000)   (127,000)
Common Stock issued upon settlement of restricted stock units, net (in Shares) 57,192      
Net Loss (422,000) (422,000)
Balance at Jun. 30, 2025 $ 4,000 85,779,000 (70,517,000) 15,266,000
Balance (in Shares) at Jun. 30, 2025 3,862,103      
Common Stock issued to directors 14,000 14,000
Common Stock issued to directors (in Shares) 4,064      
Stock-Based Compensation 152,000 152,000
Common Stock issued for cash $ 1,000 3,454,000 3,455,000
Common Stock issued for cash (in Shares) 905,787      
Net Loss (44,000) (44,000)
Balance at Sep. 30, 2025 $ 5,000 $ 89,399,000 $ (70,561,000) $ 18,843,000
Balance (in Shares) at Sep. 30, 2025 4,771,954